These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7007404)

  • 1. Suppression of captopril-induced increase in plasma renin activity by des-Asp1-,Ileu8-angiotensin II in man.
    Kono T; Ikeda F; Oseko F; Imura H; Endo J
    J Clin Endocrinol Metab; 1981 Feb; 52(2):354-8. PubMed ID: 7007404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of des-Asp1-,Ileu8-angiotensin II (Ileu8-angiotensin III) in man.
    Kono T; Oseko F; Ikeda F; Nanno M; Endo J
    J Clin Endocrinol Metab; 1976 Oct; 43(4):940-3. PubMed ID: 977730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of inhibition of ACTH-induced aldosterone stimulation by des-asp1-,ileu8-angiotensin II in man.
    Ikeda F; Kono T; Oseko F; Imura H; Endo J
    Endocrinol Jpn; 1979 Oct; 26(5):631-4. PubMed ID: 230961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiotensin III action by DES-ASP1-,ILEU8-angiotensin II in man.
    Kono T; Ikeda F; Oseko F; Nanno M; Imura H; Endo J
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):359-66. PubMed ID: 580136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of des-asp1-des-arg2-angiotensin II in man.
    Kono T; Ikeda F; Oseko F; Ohmori Y; Nakano R; Muranaka H; Taniguchi A; Imura H; Khosla MC; Bumpus FM
    Acta Endocrinol (Copenh); 1982 Apr; 99(4):577-84. PubMed ID: 7041505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of des-Asp1-angiotensin I in man.
    Kono T; Ikeda F; Oseko F; Imura H; Endo J
    J Clin Endocrinol Metab; 1980 Jan; 50(1):40-5. PubMed ID: 7350186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin I-converting enzyme inhibitor, SQ 14225, in nomal men.
    Kono T; Ikeda F; Oseko F; Imura H; Endo J
    Endocrinol Jpn; 1979 Jun; 26(3):411-8. PubMed ID: 383475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients.
    Manhem P; Bramnert M; Hulthén UL; Hökfelt B
    Eur J Clin Invest; 1981 Oct; 11(5):389-95. PubMed ID: 6800810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of captopril on renin, angiotensin II, cortisol and aldosterone during ACTH-infusion in man.
    Oelkers W; Belkien L; Baumann J; Meyland M
    Clin Exp Hypertens A; 1982; 4(9-10):1505-17. PubMed ID: 6291811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
    Ruilope LM; Miranda B; Robles RG; Hammond TG; Sancho J; Romero JC; Rodicio JL
    Postgrad Med J; 1986; 62 Suppl 1():90-3. PubMed ID: 3534868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
    Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of dexamethasone and captopril on plasma aldosterone response to exogenous angiotensin II in normal men (author's transl)].
    Mizuno K; Gotoh M; Haruyama K; Yamazaki M; Shigetomi S; Matsui J; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1981 Aug; 57(8):1109-17. PubMed ID: 7032984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.